Clinical Trial Update: Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma

View source ↗

Summary

A completed clinical trial evaluating macular ganglion cell analysis (GCA) using Cirrus HD-OCT in glaucoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Snippet

Sponsor: Carl Zeiss Meditec, Inc. | Conditions: Glaucoma | Status: COMPLETED